Anti-SIT1/ SIT/ SIT-R monoclonal antibody

Anti-SIT1/ SIT/ SIT-R antibody for FACS & in-vivo assay

Target products collectionGo to SIT1/SIT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1530-Ab-1/ GM-Tg-hg-MP1530-Ab-2Anti-Human SIT1 monoclonal antibodyHuman
GM-Tg-rg-MP1530-Ab-1/ GM-Tg-rg-MP1530-Ab-2Anti-Rat SIT1 monoclonal antibodyRat
GM-Tg-mg-MP1530-Ab-1/ GM-Tg-mg-MP1530-Ab-2Anti-Mouse SIT1 monoclonal antibodyMouse
GM-Tg-cynog-MP1530-Ab-1/ GM-Tg-cynog-MP1530-Ab-2Anti-Cynomolgus/ Rhesus macaque SIT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1530-Ab-1/ GM-Tg-felg-MP1530-Ab-2Anti-Feline SIT1 monoclonal antibodyFeline
GM-Tg-cang-MP1530-Ab-1/ GM-Tg-cang-MP1530-Ab-2Anti-Canine SIT1 monoclonal antibodyCanine
GM-Tg-bovg-MP1530-Ab-1/ GM-Tg-bovg-MP1530-Ab-2Anti-Bovine SIT1 monoclonal antibodyBovine
GM-Tg-equg-MP1530-Ab-1/ GM-Tg-equg-MP1530-Ab-2Anti-Equine SIT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1530-Ab-1/ GM-Tg-hg-MP1530-Ab-2; GM-Tg-rg-MP1530-Ab-1/ GM-Tg-rg-MP1530-Ab-2;
GM-Tg-mg-MP1530-Ab-1/ GM-Tg-mg-MP1530-Ab-2; GM-Tg-cynog-MP1530-Ab-1/ GM-Tg-cynog-MP1530-Ab-2;
GM-Tg-felg-MP1530-Ab-1/ GM-Tg-felg-MP1530-Ab-2; GM-Tg-cang-MP1530-Ab-1/ GM-Tg-cang-MP1530-Ab-2;
GM-Tg-bovg-MP1530-Ab-1/ GM-Tg-bovg-MP1530-Ab-2; GM-Tg-equg-MP1530-Ab-1/ GM-Tg-equg-MP1530-Ab-2
Products NameAnti-SIT1 monoclonal antibody
Formatmab
Target NameSIT1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SIT1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SIT1/ SIT/ SIT-R VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP004401human SIT1 Lentivirus plasmid
    ORF Viral VectorvGMLP004401human SIT1 Lentivirus particle
    ORF Viral VectorpGMLPm003503mouse Sit1 Lentivirus plasmid
    ORF Viral VectorpGMLPm004880mouse Sit1 Lentivirus plasmid
    ORF Viral VectorvGMLPm003503mouse Sit1 Lentivirus particle
    ORF Viral VectorvGMLPm004880mouse Sit1 Lentivirus particle


    Target information

    Target IDGM-MP1530
    Target NameSIT1
    Gene ID27240,54390,500449,697087,611919,101087016,512027,100067968
    Gene Symbol and SynonymsSIT,SIT-R,SIT1
    Uniprot AccessionQ9Y3P8,Q5M869
    Uniprot Entry NameSIT1_HUMAN,SIT1_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000137078
    Target ClassificationN/A

    The target: SIT1, gene name: SIT1, also named as SIT, SIT-R. Enables kinase binding activity. Involved in regulation of T cell activation. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.